Most coins are worth their face value, but others are different story. Coin collectors seek rare currencies often valued at a ...
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target of $64.00. The company’s shares closed yesterday ...
J.P. Morgan analyst Anupam Rama maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) on March 6 and set a price target of $104.00. The company’s shares closed ...